Science
Clinical Trials Clinical Studies Epidemiology Vaccine Development Cancer Research Neuroscience Vaccine Research Vaccine Safety Oncology Vaccines
The offer targets Ixo-vec, a one-time treatment for wet age-related macular degeneration now in a late-stage trial.